Silence Therapeutics plc Weighted Average Share Price Share Options Granted2019
Silence Therapeutics plc (SLNCF) reported Weighted Average Share Price Share Options Granted2019 of 3.24 GBP/shares for the 12-month period ending 2020-12-31, per its 20-F/A filed 2021-04-29.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 · last filed 2021-04-29
| Period end | Weighted Average Share Price Share Options Granted2019 12 month |
|---|---|
| 2020-12-31 | 3.24 GBP/shares 20-F/A · filed 2021-04-29 |
| 2019-12-31 | 1.19 GBP/shares 20-F/A · filed 2021-04-29 |
| 2018-12-31 | 1.47 GBP/shares 20-F/A · filed 2021-04-29 |